AVROXA
Technologiepark-Zwijnaarde 82
9052 Gent
BE
AVROXA
Foundation date
10/01/2018
Sector
#Medical TechnologySubsector
- #Medtech - Biomaterials
- #Medtech - Coatings
- #Medtech - Delivery devices
- #Medtech - Diagnostic devices
- #Medtech - Non-active implantable devices
- #Medtech - Regenerative Medicine
AVROXA is a research and manufacturing company committed to the development of innovative solutions based on our versatile proprietary polymer platform technology of poly(2-oxazoline)s (abbreviated as POZ, PAOx,POX). We develop a vast range of high-quality, well-defined, ultra-pure poly(2-oxazoline)s under the brandname ULTROXA(R) for applications in therapeutics, drug delivery, biomaterials and diagnostics.
Upcoming events
All events-
1212 '23
BioFIT 2023
Event by: Eurasanté -
0602 '24
Discovery to Innovation in Animal Health - 2024
Event by: Ghent University, Provaxs, Paul Dick & Associates -
0712 '23
The GxP Academy: Cleaning Validatie
Event by: Advipro
Latest news
More news-
Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China
1 day ago
Read more
-
Celyad announces management change
Friday December 1st 2023
Read more
-
Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States
Thursday November 30th 2023
Read more
Jobs
More jobs-
03/12/23
Limburg
PhD position in the field of neuroimmunology, mouse modelling and induced pluripotent stem cells
Permanent
VIB -
-
01/12/23
Antwerp, Brussels, East Flanders, Hainaut, Liège, Limburg, Luxembourg, Namur, Flemish Brabant, Walloon Brabant, West Flanders
Sales Engineer Belgium
Permanent
Thema Group Belgium
More info?
Ellen Telleir
Communication Coordinator